Heart failure & cardiomyopathies

Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-Controlled Device Trials: Insights From REDUCE LAP-HF II

Circ Popul Health OutcomesPublished randomized participants to atrial shunt or sham procedure

Authors' conclusion

In a sham-controlled device trial that collected patient-reported outcome data during blinded allocation to treatment or sham and after unblinding, the estimated mean placebo effect benefit and loss on the KCCQ-OS were small (≤2 points). Finding a modest placebo effect on patient-reported outcomes may increase confidence in their use as clinical trial outcomes.

Study context

Population
Participants of REDUCE LAP-HF II (heart failure) randomized to atrial shunt or sham procedureanalytic cohort (median age, 72 years, 65.6% female) · sham-treated 182 · shunt-treated 239
Participants
421 participants
Comparison
Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) changes before and after unblinding in sham-treated and shunt-treated patients
  • shamn = 182
  • shuntn = 239
Methodological detailssham-controlled, unblinding after 2 years
  • Sham-controlled
  • Unblinding after 2 years

Primary result

As reported in the abstract

KCCQ-OS change from baseline to 2 years (placebo effect plus other benefits from trial participation) · 2 years

Sham

+9.3

mean improvement · SD 22.4 · points

Shunt

+12.7

mean improvement · SD 22.8 · points

Further findings

Mean change, points

OutcomeShamShunt
KCCQ-OS change from 2 to 3 years after unblinding (placebo effect loss in sham; placebo effect benefit in shunt)−1.7 (SD 18.2)+1.9 (SD 18.2)

Combined placebo effects in a hypothetical unblinded trial

Combined effects
3.6 points
  • Hypothetical unblinded trial where placebo effect benefit would be expected in the active intervention arm, and none in the untreated arm

Original publication

Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-Controlled Device Trials: Insights From REDUCE LAP-HF II. Circ Popul Health Outcomes. Published 12 January 2026. doi:10.1161/circoutcomes.125.012676

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.